Sort
15,273 grants matching “antimicrobial resistance”
A High-Throughput Molecular Platform for Antimicrobial Discovery and Study
$417,235Bryan William Davies · University Of Texas At Austin · R01 · FY2016 · AI
Integrated modeling of Klebsiella pneumoniae infections based on bacterial genotype, patient factors and colonization status
$417,192Michael Abbott Bachman · University Of Michigan At Ann Arbor · R01 · FY2021 · AI
Regulation and Manipulation of Oral Type III Interferon Responses by Porphyromonas gingivalis
$417,169Juhi Bagaitkar · Research Inst Nationwide Children'S Hosp · R01 · FY2025 · DE
Subproject 4: Role of Pumps in Resistance, Physiology, and Infection
$417,153David C Hooper · Massachusetts Eye And Ear Infirmary · P01 · FY2024 · AI
Rapid molecular diagnostic for chlamydia and gonorrhea at the point-of-care
$417,101Catherine M. Klapperich · Boston University (Charles River Campus) · R01 · FY2016 · AI
Controlling Catheter-Associated Urinary Tract Infections Using Smart Catheters with Rationally Designed Active Topographies
$417,058Dacheng Ren · Syracuse University · R01 · FY2024 · EB
Role of Toxins in Endophthalmitis
$416,988Michael S. Gilmore · Massachusetts Eye And Ear Infirmary · R01 · FY2011 · EY
Role of Toxins in Endophthalmitis
$416,988Michael S. Gilmore · Massachusetts Eye And Ear Infirmary · R01 · FY2012 · EY
Enhancing Collectin Mediated Defense Against Influenza
$416,925Kevan L Hartshorn · Boston Medical Center · R01 · FY2012 · HL
Enhancing Collectin Mediated Defense Against Influenza
$416,875Kevan L Hartshorn · Boston Medical Center · R01 · FY2011 · HL
Transforming Translational Science and Education to benefit human health
$416,808Barry Coller · Rockefeller University · UL1 · FY2012 · TR
Novel Azole Resistance Mechanisms in Candida albicans
$416,764P David Rogers · University Of Tennessee Health Sci Ctr · R01 · FY2019 · AI
T-Cell response to CD1-restricted lipids in Tuberculosis
$416,742David Branch Moody · Brigham And Women'S Hospital · R01 · FY2009 · AI
T-Cell response to CD1-restricted lipids in Tuberculosis
$416,742David Branch Moody · Brigham And Women'S Hospital · R01 · FY2008 · AI
Enhancing surveillance systems to slow the spread of antimicrobial-resistant gonorrhea in the United States
$416,735Reza Yaesoubi · Yale University · R01 · FY2022 · AI
Enhancing surveillance systems to slow the spread of antimicrobial-resistant gonorrhea in the United States
$416,735Reza Yaesoubi · Yale University · R01 · FY2023 · AI
Enhancing surveillance systems to slow the spread of antimicrobial-resistant gonorrhea in the United States
$416,735Reza Yaesoubi · Yale University · R01 · FY2024 · AI
Enhancing surveillance systems to slow the spread of antimicrobial-resistant gonorrhea in the United States
$416,735Reza Yaesoubi · Yale University · R01 · FY2021 · AI
Natural Phenolic Compounds against Oral Candidiasis (OC)
$416,396Eleftherios Mylonakis · Methodist Hospital Research Institute · R01 · FY2024 · AI
Phage resistance and mobile genetic elements in Vibrio cholerae
$416,292Kimberley Diane Seed · University Of California Berkeley · R01 · FY2016 · AI
Molecular Biology and Virulence of CTX Phage
$416,276Matthew K Waldor · Brigham And Women'S Hospital · R37 · FY2014 · AI
GBPs as new inflammsome regulators during mammalian host defense
$416,250John D Macmicking · Yale University · R01 · FY2016 · AI
GBPs as new inflammsome regulators during mammalian host defense
$416,250John D Macmicking · Yale University · R01 · FY2017 · AI
GBPs as new inflammsome regulators during mammalian host defense
$416,250John D Macmicking · Yale University · R01 · FY2015 · AI
GBPs as new inflammsome regulators during mammalian host defense
$416,250John D Macmicking · Yale University · R01 · FY2014 · AI